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OBJECTIVES This study was designed to determine if the fatty acid-induced increase in H production
from glycolysis uncoupled from glucose oxidation delays the recovery of intracellular pH
(pHi) during reperfusion of ischemic hearts.
BACKGROUND High rates of fatty acid oxidation inhibit glucose oxidation and impair the recovery of
mechanical function and cardiac efficiency during reperfusion of ischemic hearts.
METHODS pHi was measured by
31P nuclear magnetic resonance spectroscopy in isolated working rat
hearts perfused in the absence (5.5 mmol/l glucose) or presence of 1.2 mmol/l palmitate
(glucosepalmitate). Glycolysis and glucose oxidation were measured using [5-3H/U-
14C]glucose.
RESULTS When glucosepalmitate hearts were subjected to 20 min of no-flow ischemia, recoveries of
mechanical function and cardiac efficiency were significantly impaired compared with glucose
hearts. Glucose oxidation rates were significantly lower in glucosepalmitate hearts during
reperfusion compared with glucose hearts, whereas glycolysis rates were unchanged. This
resulted in an increase in H production from uncoupled glucose metabolism, and a
decreased rate of recovery of pHi in glucosepalmitate hearts during reperfusion compared
with glucose-perfused hearts. Dichloroacetate (3 mmol/l) given at reperfusion to
glucosepalmitate hearts resulted in a 3.2-fold increase in glucose oxidation, a 35%  3%
decrease in H production from glucose metabolism, a 1.7-fold increase in cardiac efficiency
and a 2.2-fold increase in the rate of pHi recovery during reperfusion.
CONCLUSIONS A high level of fatty acid delays the recovery of pHi during reperfusion of ischemic hearts
because of an increased H production from glycolysis uncoupled from glucose oxidation.
Improving the coupling of glucose metabolism by stimulating glucose oxidation accelerates
the recovery of pHi and improves both mechanical function and cardiac efficiency. (J Am
Coll Cardiol 2002;39:718–25) © 2002 by the American College of Cardiology
During ischemia, anaerobic glycolysis is an important source
of adenosine triphosphate (ATP) production (1). However,
H production from the hydrolysis of glycolytically pro-
duced ATP also contributes to the acidosis that occurs in
ischemic myocardium (2). Development of cellular acidosis
decreases cardiac pressure development (3) and provokes
cardiac arrhythmias (4). Acidosis can also decrease contrac-
tility by decreasing the response of contractile proteins to
Ca, predominantly by a decrease in Ca binding to
troponin C as protons compete with Ca at Ca-
binding sites (4). Intracellular acidosis during severe isch-
emia also increases sarcolemmal Na/H exchange (5,6). If
the myocardium is reperfused, extracellular pH quickly
normalizes, creating a large pH gradient across the mem-
brane, and the resultant activation of Na/H exchange
increases intracellular Na. This Na then alters Na/
Ca exchange activity, leading to intracellular Ca
overload and cell death (5,6). Inhibition of Na/H ex-
changer improves the recovery of cardiac function and
efficiency during reperfusion (7–9), emphasizing that the
accumulation of intracellular H during ischemia is an
important contributing factor to ischemic injury. Whether
continued production of H during the critical early period
of reperfusion also has the potential to exacerbate ischemia-
reperfusion injury has not been established.
In most clinical situations of reperfusion after ischemia,
the heart muscle is exposed to high levels of fatty acids (10).
Reperfusion of reversibly injured ischemic muscle results in
a rapid recovery of fatty acid oxidation, with rates often
exceeding pre-ischemic levels (11,12). This high rate of fatty
acid oxidation inhibits the rate of glucose oxidation to a
much greater extent than the rate of glycolysis, resulting in
a marked uncoupling between the rates of glycolysis and
glucose oxidation (13–16). This uncoupling of glucose
metabolism is a potentially important source of H produc-
tion during reperfusion (13,15,16). If glycolysis is coupled to
glucose oxidation, H production from hydrolysis of ATP
derived from glucose metabolism is zero (13,17). However,
if glycolysis is uncoupled from glucose metabolism (and
pyruvate derived from glycolysis is not oxidized), there is a
net production of two H from each glucose molecule
metabolized. As a result, high rates of fatty acid oxidation
during the actual reperfusion period have the potential to
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increase H production generated from uncoupled glucose
metabolism (13–16). Whether this translates into differ-
ences in pHi recovery after ischemia is not known.
Although 31P-nuclear magnetic resonance (31P-NMR) is
the standard for pHi measurements, to our knowledge no
previous studies have used this technique to assess directly
the effects of fatty acids on rates of pHi recovery after
ischemia. We therefore directly measured pHi in isolated
working rat hearts in the presence and absence of a high
level of fatty acid. Using this approach we compared rates of
pHi recovery after ischemia to rates of H
 production
calculated from measurements of glycolysis and glucose
oxidation. We also determined whether stimulation of
glucose oxidation with dichloroacetate (DCA), a pyruvate
dehydrogenase activator (14,18), could improve the recovery
of cardiac function and efficiency by accelerating the recov-
ery of pHi during reperfusion.
METHODS
Isolated working rat hearts. Rat hearts were cannulated
for isolated working heart perfusions, as described previ-
ously (13). All procedures on animals conformed with the
guidelines of the Canadian Council on Animal Care and
were approved by the University of Alberta Health Sciences
Animal Policy Committee. In brief, male Sprague-Dawley
rats (0.3 to 0.35 kg) were anesthetized with pentobarbital
sodium (60 mg/kg i.p.), and the hearts were quickly excised,
cannulated as working hearts, and perfused at a
11.5 mm Hg left atrial pre-load and 80 mm Hg aortic
after-load. Spontaneously beating working hearts were per-
fused with Krebs-Henseleit solution containing 2.5 mmol/l
calcium, 5.5 mmol/l glucose and 3% bovine serum albumin,
in the presence or absence of 1.2 mmol/l palmitate, as
described previously (19). Heart rate, aortic pressure, cardiac
output, aortic flow, coronary flow, coronary resistance,
myocardial O2 consumption (MVO2), cardiac work and
cardiac efficiency were determined, as described previously
(14,19).
The isolated working hearts were adapted for use within
the confines of a magnet by methods described in the
literature (20,21). Because measurement of glucose metab-
olism using radiolabeled tracers requires that the whole
perfusion system to be sealed (22), we developed a perfusion
system that permitted efficient operation of a closed system
within the confines of a high field magnet. Identical
perfusion systems were used for the metabolic and 31P
NMR studies. The detailed tubing connections for the
working heart have been shown previously (20,21). To
optimize the performance of the working heart within the
magnet, the oxygenator was placed within the bore of the
magnet 15 cm above the heart, thereby providing the
appropriate pre-load. The bottom part of the cannula
assembly (heart chamber) was designed to fit within a
25-mm NMR tube. Coronary flow entered the space
around the heart and was removed by a suction tube
working directly off a peristaltic pump. Thus, the heart was
always surrounded by perfusate up to the level of the aorta.
In addition, the aortic outflow line, after leaving the
compliance chamber, proceeded out of the magnet and into
the perfusate reservoir for recirculation. This aortic outflow
line provided the resistance necessary to generate 80 mm Hg
hydrostatic pressure (afterload) on the heart. Perfusion lines
were water-jacked to maintain perfusate temperature of
37°C. Total perfusate volume in the recirculating system
was 150 ml.
Experimental protocol. Working hearts were initially per-
fused for 30 min under aerobic conditions. Global no-flow
ischemia was then introduced by clamping both the left
atrial inflow and aortic outflow lines. The left atrial inflow
was clamped by an extension rod attached to a clamp
positioned between the oxygenator and the heart. After
20 min of no-flow ischemia (33°C), the left atrial and aortic
flows were restored, and the hearts were reperfused for
40 min under aerobic conditions. Experimental groups
included: 1) 5.5 mmol/l glucose throughout (glucose); 2)
5.5 mmol/l glucose and 1.2 mmol/l palmitate throughout
(glucosepalmitate); and 3) 5.5 mmol/l glucose and
1.2 mmol/l palmitate throughout, with 3 mmol/l DCA
(BDH Chemicals Ltd., Toronto, Canada) added immediately
before post-ischemic reperfusion (glucosepalmitateDCA).
At the end of reperfusion, hearts were quickly frozen with
Wollenberger clamps cooled to the temperature of liquid N2
for dry weight-to-wet weight ratio determinations.
Measurement of glycolysis and glucose oxidation.
Glycolysis and glucose oxidation were measured simulta-
neously by perfusing hearts with [5-3H/U-14C] glucose
(13,22). The total myocardial 3H2O production and
14CO2
production were determined at 10-min intervals during
both the initial aerobic perfusion period and the 40-min
period of reperfusion.
If glucose passes through glycolysis to lactate and the
ATP so formed is hydrolyzed, a net production of 2 H per
molecule of glucose occurs (10,14). In contrast, if glycolysis
is coupled to glucose oxidation, the net production of H is
zero. Therefore, the overall rate of H production derived
from glucose utilization was calculated by subtracting the
rate of glucose oxidation from the rate of glycolysis and
multiplying by 2.
Determination of pHi by
31P-NMR spectroscopy. 31P-
NMR spectra were acquired using a Bruker Advance 500
spectrometer in conjunction with a 120 mm vertical bore
Abbreviations and Acronyms
ATP  adenosine triphosphate
DCA  dichloroacetate
ECLA  Estudios Cardiologicos Latinoamerica
GIK  glucose-insulin-potassium
MCT  lactate-H cotransporter
MVO2  myocardial oxygen consumption
NMR  nuclear magnetic resonance
PCr  phosphocreatine
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11.7T magnet (Magnex, Oxford, U.K.). Under the same
perfusion conditions as used for the metabolic studies, the
working hearts were positioned within a 25-mm dual
channel NMR probe (Morris Instruments, Gloucester,
Ontario, Canada). Cardiac function was comparable in both
series of experiments. Field homogeneity was adjusted by
shimming on the proton signal using the 1H channel and
yielded line widths of approximately 0.1 ppm. 31P spectra
were acquired at 202.4 MHz with a time resolution of 2.25
min (1.12 min at the end of ischemia and first 10 min of
reperfusion), using a 60° pulse and a 1.8-s recycle time.
Spectra were processed using WIN NMR (Bruker) by
summing 72 (or 36) free induction decays and subjected to
Fourier transform after exponential multiplication (line
broadening  30). The content of high energy phosphates
was determined by integration of the areas under the peaks.
During an initial stabilization period of 30 min aerobic
perfusion, which included the time required for tuning of
the probe and shimming of the magnet, baseline spectra
were acquired before the onset of ischemia. pHi was
determined from the chemical shift of phosphate relative to
phosphocreatine (PCr) with a calibration curve obtained by
titrating phosphate in a solution mimicking the intracellular
milieu (23).
Statistical analysis. All data are presented as the mean 
SEM for “n” observations. We tested the treatment-time
interaction by two-way analysis of variance with repeated
measures on time. We used Mauchly’s test to assess the
assumption of compound symmetry in each data set. If
Mauchly’s test rejected this assumption, the Huyhn-Feldt
epsilon correction was used to adjust error degrees of
freedom for tests of the treatment-time interaction effect.
Differences were judged to be significant when p  0.05
(two-tailed test).
RESULTS
Effects of palmitate on the recovery of cardiac function
and efficiency. Figure 1 shows the effects of 1.2 mmol/l
palmitate on the recovery of the cardiac work in aerobic and
reperfused ischemic hearts. Baseline pre-ischemic values for
cardiac work, heart rate, peak systolic pressure, developed
pressure, cardiac output, coronary flow and coronary resis-
tance did not differ between glucosepalmitate and glucose
hearts (data not shown). Baseline pHi values in
glucosepalmitate and glucose hearts were also not differ-
ent during the pre-ischemic period (7.16 0.02 and 7.14
0.03, respectively, at the end of 30 min aerobic perfusion).
Hearts were subjected to 20 min of global ischemia because
this period resulted in a near-complete recovery of cardiac
work in glucose heart (83%  8% of pre-ischemic values).
However, in glucosepalmitate hearts, the recovery of
cardiac work was dramatically depressed, returning to only
30%  8% of pre-ischemic values by 40 min of reperfusion
(Fig. 1). Heart rate (105  26 vs. 238  8 beats/min), peak
systolic pressure (68  13 vs. 124  12 mm Hg), cardiac
output (25  4 vs. 45  4 ml/min), and coronary flow (9 
4 vs. 21  2 ml/min) were all significantly depressed during
reperfusion in glucosepalmitate hearts compared with
glucose hearts. No difference in coronary resistance was
observed during reperfusion in the glucose and
glucosepalmitate hearts (4.6  0.7 vs. 6.0  0.8 mm
Hg/min/ml). After ischemia, MVO2 in glucose hearts
recovered to pre-ischemic values (47 5 vs. 48 4 mol/g
dry wt/min), which was accompanied by a near-complete
Figure 1. Effects of palmitate on the recovery of cardiac work, cardiac
efficiency and pHi of isolated working rat hearts reperfused after ischemia.
Values are mean  SEM of eight glucose-perfused hearts (open circles)
and eight glucosepalmitate perfused hearts (closed circles). 31P-NMR
measurement of pHi was performed as described in the Methods section.
Isolated working hearts were subjected to 20 min of global no-flow
ischemia, followed by 40 min of aerobic reperfusion. *Significant time-
treatment interaction as determined by two-way analysis of variance with
repeated measures on time. After application of the Huyhn-Feldt correc-
tion, p values for the time-treatment interactions for cardiac work, cardiac
efficiency and pHi are 0.004, 0.007 and 0.0001, respectively.
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recovery of cardiac work (Fig. 1). MVO2 was significantly
depressed during reperfusion of glucosepalmitate hearts
(24  4 vs. 45  8 mol/g dry wt/min). However, this
depression of MVO2 was less severe than the decrease in
cardiac work observed in these hearts, leading to a signifi-
cant decrease in cardiac efficiency throughout the entire
40-min reperfusion period (Fig. 1).
Effects of palmitate on the recovery of pHi. The effect of
palmitate on pHi during ischemia and reperfusion is shown
in Figure 1. As expected, pHi decreased during ischemia,
but the extent and rate of this decrease did not differ
between the glucosepalmitate and the glucose hearts.
Within the first 3 min of reperfusion there was a 30%
recovery of pHi in both groups, with no differences in the
rate of recovery between the glucose and glucosepalmitate
groups. However, pHi in the glucose hearts quickly recov-
ered to pre-ischemic values within the next 2 min of
reperfusion, whereas in the glucosepalmitate groups, com-
plete recovery of pHi required 35 min of reperfusion.
Effects of palmitate on glucose metabolism and H
production. Cumulative glycolysis and glucose oxidation
rates were obtained throughout the entire perfusion period,
with rates being linear in both the glucosepalmitate and
glucose hearts during the pre-ischemic and post-ischemic
periods (Fig. 2). Glycolytic rates in these hearts were lower
than rates we have observed in previous studies (13,14).
These lower rates are probably related to the lower glucose
concentration used in this study (5.5 mmol/l) compared
with our previous studies (11 mmol/l). No significant
difference in glycolysis rates was observed during reperfusion
between the glucosepalmitate and glucose hearts. How-
ever, glucose oxidation was significantly depressed in
glucosepalmitate hearts compared with glucose hearts.
This resulted in a substantial uncoupling of glycolysis from
glucose oxidation, resulting is a significantly higher rate of
H production from glucose metabolism during reperfusion
in the glucosepalmitate hearts compared with the glucose
hearts (Fig. 2).
Effects of dichloroacetate on the recovery of cardiac
function and efficiency. To determine if stimulating glu-
cose oxidation could overcome the detrimental effects of
palmitate on cardiac function and pHi recovery, DCA was
added to the perfusate at the onset of reperfusion in the
glucosepalmitate hearts (14,18). Dichloroacetate stimu-
lates pyruvate dehydrogenase, the rate-limiting enzyme for
glucose oxidation. Figure 3 shows the effects of DCA on the
recovery of cardiac work and cardiac efficiency during
reperfusion after ischemia. Similar to the results from Figure
1, the recovery of cardiac work was dramatically depressed
in hearts perfused with glucosepalmitate, returning to
only 38%  3% of pre-ischemic values at 40 min of
reperfusion. Heart rate (106  22 vs. 234  7 beats/min),
peak systolic pressure (70  12 vs. 120  13 mm Hg),
cardiac output (26  3 vs. 42  4 ml/min) and coronary
flow (10  2 vs. 21  2 ml/min) were also significantly
depressed in these hearts during the post-ischemic period,
as was cardiac efficiency (Fig. 3). If DCA was present during
reperfusion, cardiac work recovered to 74%  6% of
pre-ischemic values at the end of reperfusion, compared
with 38  3% in untreated hearts. Heart rate (226  26 vs.
106  22 beats/min), peak systolic pressure (112  13 vs.
79  12 mm Hg), cardiac output (39  4 vs. 26  3
ml/min) and coronary flow (19  3 vs. 10  2 ml/min) also
recovered to a significantly greater extent during reperfu-
sion. No difference in coronary resistance was observed
Figure 2. Effects of 1.2 mmol/l palmitate on cumulative rates of glycolysis,
glucose oxidation and H production from glucose metabolism during
reperfusion of ischemic hearts. Values are means  SEM of eight glucose
perfused hearts (open circles) and eight glucosepalmitate perfused hearts
(closed circles). Hearts were subjected to 30 min of aerobic perfusion, 20
min of global no-flow ischemia and 40 min of aerobic reperfusion.
Pre-ischemic values taken at 30 min of aerobic perfusion. Values were
determined between 10 and 40 min of reperfusion *Significant time-
treatment interaction as determined by two-way analysis of variance with
repeated measures on time. After application of the Huyhn-Feldt correc-
tion, p values for the time-treatment interactions for glycolysis, glucose
oxidation and proton production are 0.533, 0.0001 and 0.0001,
respectively.
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during reperfusion in the glucosepalmitateDCA and
glucose palmitate hearts (5.1  0.5 vs. 4.6  0.8 mm
Hg/min/ml1). At the end of the 40-min reperfusion
period, cardiac work in the glucosepalmitateDCA
group recovered to 74  6% of pre-ischemic values. This
was accompanied by an overall recovery of MVO2 to 61 
4% of pre-ischemic values. As a result, a complete recovery
of cardiac efficiency (cardiac work/O2 consumed) was ob-
served in the glucosepalmitateDCA group (to 104 
7% of pre-ischemic values) (Fig. 3). This contrasted with
the 63%  5% recovery of cardiac efficiency in the
glucosepalmitate group.
Effects of dichloroacetate on pHi recovery after ischemia.
The effect of DCA on pHi during the reperfusion period is
shown in Figure 3. If DCA was present during reperfusion,
a significant increase in the rate of pHi recovery after
ischemia was observed. A complete recovery of pHi required
10 min of reperfusion in the glucosepalmitateDCA
hearts, compared with 35 min in the glucosepalmitate
hearts.
Effects of dichloroacetate on glucose metabolism, and
H production from glucose metabolism after ischemia.
Cumulative rates of glycolysis, glucose oxidation and H
production during reperfusion are shown in Figure 4.
During reperfusion, DCA selectively increased the rate of
glucose oxidation with no significant effect on the rate of
glycolysis. During reperfusion, DCA increased glucose ox-
idation rate to 406%  38% of glucose palmitate alone
rates, resulting in a 35  3% decrease in H production
from glycolysis uncoupled from glucose oxidation (Fig. 4).
The decrease in H production during reperfusion in the
glucosepalmitateDCA treated hearts was not as dra-
matic as that seen in the glucose-alone hearts (Fig. 2). This
may explain why the recoveries of cardiac work and cardiac
efficiency were slower in the glucosepalmitateDCA
hearts (Fig. 3), compared with the glucose-alone hearts
(Fig. 1).
DISCUSSION
Proton production and cardiac efficiency. Myocardial
energy substrate preference is an important determinant of
the ability of cardiac muscle to recovery after an ischemic
episode (15,16,23–25). In this study we confirm that a high
level of fatty acid (which is seen in most clinically relevant
conditions of ischemia) markedly inhibits glucose oxidation
during reperfusion of ischemic hearts (14–16). An impor-
tant novel finding is that the resulting calculated increase in
H production from glycolysis uncoupled from glucose
oxidation was accompanied by a delayed recovery of mea-
sured pHi during reperfusion. This contributes to a fatty
acid-induced decrease in recovery of both mechanical func-
tion and cardiac efficiency during reperfusion. The second
important finding from this study is that directly stimulating
glucose oxidation in fatty-acid perfused hearts (with DCA)
accelerates the recovery of pHi during reperfusion, second-
ary to a decrease in H production from glucose metabo-
lism. Confirming our previous studies, this stimulation of
glucose oxidation was accompanied by a significant im-
provement in mechanical function and cardiac efficiency
during reperfusion (14–16). Of interest is that the beneficial
effects of stimulating glucose oxidation occurred during the
actual reperfusion period. It is well known that H accu-
mulation during ischemia is an important contributing
factor to ischemic injury (2,26). Our results demonstrate
that continued production of H during the actual reper-
Figure 3. Effects of dichloroacetate (DCA) on the recovery of cardiac
work, cardiac efficiency and pHi of hearts reperfused after ischemia. Values
are mean  SEM of eight glucosepalmitate perfused hearts (closed
circles) and eight glucosepalmitate  DCA perfused hearts (closed
triangles). Isolated working hearts were subjected to 20 min of global
no-flow ischemia and 40 min of aerobic reperfusion. DCA (3 mmol/l) was
added immediately before reperfusion. *Significant time-treatment inter-
action as determined by two-way analysis of variance with repeated
measures on time. After application of the Huyhn-Feldt correction,
p-values for the time-treatment interaction for cardiac work, cardiac
efficiency and pHi are 0.004, 0.008 and 0.0001, respectively.
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fusion period can also contribute to ischemic injury. The
detrimental effects of palmitate on cardiac work and effi-
ciency during reperfusion were not accompanied by an
increase in coronary resistance. Similarly, the increase in
cardiac work and efficiency in glucosepalmitate hearts
perfused with DCA was not accompanied by changes in
coronary resistance.
Fatty acid inhibition of pH recovery after ischemia.
Although 31P-NMR is an effective approach to measure
pHi in the heart, few studies have used this technique in
vitro to measure pHi during and after ischemia in hearts
perfused with the high levels of fatty acids seen in vivo
during and after ischemia. To our knowledge, no previous
study has specifically looked at the effects of high levels of
fatty acids on rates of pHi recovery, nor has pHi recovery
been directly compared with calculated rates of H produc-
tion from glycolysis and glucose oxidation. Because meta-
bolic rates are dependent on the work performed by the
heart, we developed techniques that allowed measurement
of pHi in isolated working rat hearts perfused in the
presence of a high level of fatty acids (1.2 mmol/l palmitate).
During an episode of global no-flow ischemia, the decrease
in pHi in the glucose-perfused hearts was similar to the
decrease observed in numerous previous studies (27–29). Of
interest is that during ischemia the presence of a high level
of fatty acids had no effect on the rate or extent of the
decrease in pHi. However, during reperfusion the presence
of palmitate markedly slowed the rate of pHi recovery. Our
data suggest that this decreased rate of recovery of pHi was
the result of a fatty acid-induced increase in H production,
as opposed to an alteration in the fate of the H produced.
Our data also suggest that this increased H burden
contributes to the decrease in cardiac work and cardiac
efficiency during reperfusion, because prevention of the fatty
acid–induced increase in H production (by stimulating
glucose oxidation or by omitting fatty acids) improved the
recovery of both cardiac work and cardiac efficiency.
Proton clearance after ischemia. There are at least four
different mechanisms that contribute to the recovery of pHi
from acidosis in the heart: the Na/H exchanger (7), the
lactate-H cotransporter (MCT) (30), the vacuolar-H
ATPase (31), and the Na/HCO3
1 cotransporter (32).
The Na/H exchanger is an important determinant of the
fate of H during reperfusion, but the clearance of H is
associated with the influx of Na, which can subsequently
lead to the accumulation of intracellular Ca because of
alterations in Na/Ca exchange activity. This has led to
the development of Na/H exchange inhibitors that are
cardioprotective to ischemic hearts (5) by decreasing the
amount of ATP necessary to reestablish normal Na and
Ca homeostasis (33). The vacuolar-H ATPase may
also be an important mechanism by which protons are
cleared during reperfusion (34), although clearance of H
by this pathway may decrease cardiac efficiency because
ATP is required for ATPase activity.
Glucose metabolism as a source of protons in the heart.
Although a considerable research effort has concentrated on
the fate of H during reperfusion of ischemic hearts, few
outside our group have focused on whether H production
during reperfusion contributes to ischemic injury. We hy-
pothesize that uncoupled glucose metabolism is an impor-
tant source of H’s during the actual reperfusion period. As
shown in Figure 2, the marked inhibition of glucose
Figure 4. Effects of dichloroacetate (DCA) on cumulative glycolysis,
glucose oxidation and H production from glucose metabolism during
reperfusion of ischemic hearts in the presence of 1.2 mmol/l palmitate.
Values are means  SEM of eight glucosepalmitate perfused hearts
(closed circles) and eight glucosepalmitateDCA perfused hearts
(closed triangles). Hearts were subjected to 30 min of aerobic perfusion,
20 min of global no-flow ischemia and 40 min of aerobic reperfusion.
Pre-ischemic values were taken at 30 min of aerobic perfusion. Values were
determined between 10 and 40 min of reperfusion. Dichloroacetate (3
mmol/l), when present, was added immediately before reperfusion. *Sig-
nificant time-treatment interaction as determined by two-way analysis of
variance with repeated measures on time. After application of the Huyhn-
Feldt correction, p values for the time-treatment interactions for glycolysis,
glucose oxidation and proton production are 0.345, 0.0001 and 0.029,
respectively.
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oxidation in the presence of a high level of fatty acid was not
accompanied by a similar decrease in glycolytic rates. As a
result, glycolysis became further uncoupled from glucose
oxidation and continued to be an important source of H
production during the actual reperfusion period. Our data
strongly suggest that this is responsible for a slower rate of
recovery of pHi during reperfusion.
Although high levels of fatty acids increase H produc-
tion in the heart, the detrimental effects of fatty acids may
be due to alterations in high energy phosphate production.
However, in our study, palmitate did not have any signifi-
cant effects on ATP, PCr or Pi content measured at the end
of ischemia, and levels of these intermediates (ATP, Pi)
during reperfusion (data not shown) did not predict the
extent of recovery. This lack of correlation between actual
levels of high energy phosphates and functional recovery
parallels what has been observed previously (35,36).
The use of glucose-insulin-potassium (GIK) solutions
has recently received a considerable amount of renewed
interest as an approach to treating acute myocardial infarc-
tion (37). The recent Estudios Cardiologicos Latinoamerica
(ECLA) study showed that GIK can significantly reduce
in-hospital mortality associated with acute myocardial in-
farction (38). Although the actual mechanism of GIK was
not established, the authors suggest that a lowering of
blood-free fatty acids contributes to the benefits of GIK.
This raises the possibility that GIK treatment lowers proton
production and improves cardiac efficiency, although this
remains to be determined.
Summary. During reperfusion, a high level of fatty acid
delays the recovery of myocardial pHi, possibly by increasing
intracellular H production from glycolysis uncoupled from
glucose metabolism. This impairs the recovery of contractile
function and cardiac efficiency in the post-ischemic period.
The reduction of H production by stimulating glucose
oxidation during reperfusion significantly improves the cou-
pling of glucose metabolism and therefore accelerates pHi
recovery. This leads to a significant improvement of the
recovery of cardiac function and efficiency.
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